Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-006405
Filing Date
2022-03-16
Accepted
2022-03-16 17:08:37
Documents
1
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164746489968363.html 4  
1 FORM 4 wf-form4_164746489968363.xml 4 4684
  Complete submission text file 0001628280-22-006405.txt   6180
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Koenig Sheldon L. (Reporting) CIK: 0001766524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 22745704